MRNA vs. TECH: Which Stock Should Value Investors Buy Now?

03:40pm, Monday, 08'th Aug 2022 Zacks Investment Research
MRNA vs. TECH: Which Stock Is the Better Value Option?
MRNA vs. TECH: Which Stock Is the Better Value Option?
Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles
Moderna CEO Stéphane Bancel discusses the reasons behind the company's Q3 success, and his anticipations for Q4. Segment originally aired on August 3, 2022.
Your portfolio is counting on you to pass the tests.
Your portfolio is counting on you to pass the tests.

Where Will Moderna Be in 1 Year?

02:53pm, Saturday, 06'th Aug 2022 The Motley Fool
The biotech's fortunes could reverse.
Has the healthcare stock been a better investment than the S&P 500?

Where Will Moderna Be in 1 Year?

10:53am, Saturday, 06'th Aug 2022
The biotech's fortunes could reverse.
The daily average for new U.S. cases may have started to decline based on official numbers, but it's unclear at this time if the trend is real as so many people are testing at home and the data are no

Is It Too Late to Buy SIGA Technologies Stock?

03:00pm, Friday, 05'th Aug 2022 The Motley Fool
The stock skyrocketed last month.
Beaten down from its highs late last year, cell engineering company Ginkgo Bioworks now looks primed to divide and conquer.
The global tally of new cases of COVID-19 fell 9% in the week through July 31, according to the World Health Organization, but the trend did not hold for the U.S., which saw new cases climb 2% to mark

Company News for Aug 4, 2022

12:31pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Companies in The News Are: MRNA, REGN, HZNP, EXC
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE